EMEA-002175-PIP01-17 - paediatric investigation plan

netarsudil

Latanoprost

Key facts

• Active substance:
  • netarsudil
  • Latanoprost
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0281/2017
• PIP number:
  EMEA-002175-PIP01-17
• Pharmaceutical form(s):
  • Eye drops, solution
  • Solution
• Condition(s) / indication(s):
  Treatment of glaucoma
• Route(s) of administration:
  Ocular use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  04/10/2017
• Compliance check done:
  No

Decision

P/0281/2017: EMA decision of 4 October 2017 on the granting of a product specific waiver for netarsudil / latanoprost (EMEA-002175-PIP01-17)

Adopted Reference Number: EMA/626326/2017